ASPECTS OF PATHOGENESIS AND DIFFERENTIATED APPROACHES TO THE TREATMENT OF SKIN PATHOLOGY IN WOMEN OF EARLY REPRODUCTIVE AGE WITH MENSTRUAL CYCLE DISORDERS

Authors

DOI:

https://doi.org/10.11603/24116-4944.2026.1.16382

Keywords:

menstrual cycle disorders, hyperandrogenism; skin pathology, androgen receptors, reproductive-age women

Abstract

The aim of the study – to determine the relationships between menstrual cycle disorders, hormonal profile, and dermatological manifestations in women of early reproductive age in order to develop a prognostic model of these disorders and ensure an adequate therapeutic response.

Materials and Methods. The study included 120 women of early reproductive age (18–35 years), who were divided into three groups according to clinical and hormonal characteristics: Group I (n=45) – women with menstrual cycle disorders and clinical signs of hyperandrogenism (acne, hirsutism, seborrhea); Group II (n=45) – women with menstrual cycle disorders without clinical signs of hyperandrogenism but with other dermatological manifestations (alopecia, xerosis, atopic dermatitis); control group (n=30) – women with a regular menstrual cycle and no skin pathology. Hormonal profile assessment and dermatological examination, including dermatoscopy and skin photometry, were performed. The severity of hirsutism was assessed using the Ferriman – Gallwey score. To evaluate tissue sensitivity, immunohistochemical analysis of androgen receptor expression in the skin was conducted. Statistical analysis was performed using descriptive statistics, correlation analysis (r), and Student’s t-test; results were considered statistically significant at p<0.05.

Results and Discussion. In patients of Group I, a significant increase in total testosterone and DHEA-S levels was observed against a background of decreased sex hormone–binding globulin. The severity of acne and hirsutism positively correlated with the free androgen index and the Ferriman – Gallwey score. In patients of Group II, systemic hyperandrogenism was minimal or absent; however, immunohistochemical analysis revealed increased androgen receptor expression in the skin, indicating the predominance of local pathogenic mechanisms. The findings confirm that dermatological manifestations in women with menstrual cycle disorders are determined not only by circulating androgen levels but also by target tissue sensitivity. This explains the clinical variability of symptoms and highlights the need for individualized therapeutic strategies based on both hormonal and receptor profiles.

Conclusions. Menstrual cycle disorders in women of early reproductive age are closely associated with hormone-dependent skin pathology. The type and severity of dermatological manifestations depend on both androgen levels and local androgen receptor expression. A comprehensive interdisciplinary approach improves the effectiveness of diagnosis and treatment.

Author Biographies

  • Vladyslav Novik, Sumy State University

    PhD Student, Department of Obstetrics, Gynecology and Family Planning

  • Iryna Nikitina, Sumy State University

    Doctor of Medical Sciences, Professor, Head of the Department of Obstetrics, Gynecology and Family Planning at the Medical Institute

  • Svitlana Herasymenko, Sumy State University

    PhD, Assistаnt Professor, Department of Obstetrics, Gynecology and Family Planning

  • Tеtіana Babar, Sumy State University

    PhD, Associate Professor, Department of Obstetrics, Gynecology and Family Planning

References

1. Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S., Legro, R. S., et al. (2023). Polycystic ovary syndrome. Nature Reviews Disease Primers, 9(1), 12. https://doi.org/10.1038/s41572-023-00417-5

2. Escobar-Morreale, H. F. (2024). Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment. Nature Reviews Endocrinology, 20(1), 35–51. https://doi.org/10.1038/s41574-023-00977-6

3. Carmina, E., & Stanczyk, F. Z. (2022). Androgen excess disorders in women: Pathophysiology and management. Endocrine Reviews, 43(3), 421–448. https://doi.org/10.1210/endrev/bnab037

4. Rosenfield, R. L., & Ehrmann, D. A. (2021). The pathogenesis of polycystic ovary syndrome: The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocrine Reviews, 42(3), 331–358. https://doi.org/10.1210/endrev/bnaa032

5. Trüeb, R. M., & Rezende, H. D. (2023). Androgenetic alopecia and hyperandrogenism in women. Dermatologic Clinics, 41(1), 45–57. https://doi.org/10.1016/j.det.2022.08.005

6. Augustin, M., Kirsten, N., Körber, A., et al. (2019). Prevalence, predictors and comorbidity of dry skin in the general population. Journal of the European Academy of Dermatology and Venereology, 33(1), 147–150. https://doi.org/10.1111/jdv.15157

7. Thiboutot, D., Dréno, B., Abanmi, A., Alexis, A. F., Araviiskaia, E., Barona Cabal, M. I., et al. (2024). Practical management of acne for clinicians: An international consensus. Journal of the European Academy of Dermatology and Venereology, 38(2), 219–231. https://doi.org/10.1111/jdv.19508

8. Ibáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., et al. (2020). An international consensus update on polycystic ovary syndrome in adolescents. Hormone Research in Paediatrics, 93(2), 71–90. https://doi.org/10.1159/000509047

9. Zouboulis, C. C., Jourdan, E., & Picardo, M. (2021). Acne is an inflammatory disease and alterations of sebum composition initiate acne lesions. Journal of the European Academy of Dermatology and Venereology, 35(1), 67–74. https://doi.org/10.1111/jdv.16978

10. Ding, Y., He, J., Wang, Y., Zhao, Y., & Chen, Z. J. (2022). Androgen receptor signaling in female reproductive and metabolic disorders. Frontiers in Endocrinology, 13, 879523. https://doi.org/10.3389/fendo.2022.879523

11. Rocha, M. A., Bagatin, E., & Machado, M. C. (2020). Adult female acne: A guide to clinical practice. Anais Brasileiros de Dermatologia, 95(6), 693–703. https://doi.org/10.1016/j.abd.2020.08.002

12. Romanenko, T. H., Ihnatyuk, T. M., & Molchanova, O. O. (2020). Suchasne likuvannya hiperandrohennykh staniv u zhinok reproduktyvnoho viku [Modern treatment of hyperandrogenic conditions in women of reproductive age]. Zdorovʺya Zhinky (Women's Health), 5–6(151–152), 66–71. https://doi.org/10.15574/HW.2020.151-152.66

13. Reznichenko, N. Yu., Reznichenko, H. I., Smiyan, S. A., & Reznichenko, Yu. H. (2023). Seboreynyy dermatyt: unikalʹni mozhlyvosti vitaminoterapiyi [Seborrheic dermatitis: Unique possibilities of vitamin therapy]. Ukrainian Journal of Dermatology, Venereology, Cosmetology, 2(89), 18–26. https://doi.org/10.30978/UJDVK2023-2-18

14. Reznichenko, N. Yu., & Reznichenko, H. I. (2024). Akne – kompleksnyy pidkhid u vyrishenni problemy [Acne: A comprehensive approach to solving the problem]. Ukrainian Medical Journal, 5(163), 1–7. https://doi.org/10.32471/umj.1680-3051.163.256053

Published

2026-05-28

Issue

Section

OBSTETRICS AND GYNECOLOGY

How to Cite

ASPECTS OF PATHOGENESIS AND DIFFERENTIATED APPROACHES TO THE TREATMENT OF SKIN PATHOLOGY IN WOMEN OF EARLY REPRODUCTIVE AGE WITH MENSTRUAL CYCLE DISORDERS. (2026). Actual Problems of Pediatrics, Obstetrics and Gynecology, 1, 52-57. https://doi.org/10.11603/24116-4944.2026.1.16382